World Journal of Surgery

, Volume 43, Issue 10, pp 2469–2476 | Cite as

Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?

  • Omair A. ShariqEmail author
  • Kabir Mehta
  • Geoffrey B. Thompson
  • Melanie L. Lyden
  • David R. Farley
  • Irina Bancos
  • Benzon M. Dy
  • William F. YoungJr.
  • Travis J. McKenzie
Original Scientific Report



Patients undergoing unilateral adrenalectomy for primary aldosteronism (PA) may have a solitary adenoma, unilateral hyperplasia, or multiple adenomas on final pathology. This study investigated whether the underlying pathological diagnosis was associated with differences in clinical presentation and postoperative outcomes.


A retrospective cohort study of patients undergoing unilateral adrenalectomy for PA from 2004 to 2015 at our institution was performed. Baseline clinical and laboratory parameters, as well as postoperative biochemical and hypertension cure rates, were compared across the three aforementioned pathological groups.


Of 206 patients who met criteria for inclusion, 152 (73.8%) had a single adenoma, 33 (16%) had unilateral hyperplasia, and 21 (10.2%) had multiple unilateral adenomas. Patients with unilateral hyperplasia were more likely to be male (81.2% vs 57.9%, P = .03), undergo left-sided adrenalectomy (78.8% vs 47.4%, P < .01), and had a lower median adrenal venous sampling lateralization index (9.8 vs 19.8, P = .04) compared to those with solitary, but not multiple unilateral adenomas. No differences were seen in age, duration of hypertension, preoperative plasma aldosterone levels, plasma renin activities, 24-h urinary aldosterone excretion, serum potassium concentrations, and the number of preoperative antihypertensive medications across all three pathological groups. All patients achieved biochemical cure following adrenalectomy, and no significant differences in the rates of hypertension cure or improvement were observed in comparisons across pathological subtype.


Clinical presentation and postoperative outcomes are similar regardless of underlying pathology in patients with PA. Because one in four patients may harbor unilateral hyperplasia or multiple adenomas, total unilateral adrenalectomy should be performed as the operation of choice over adrenal-sparing approaches.


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Young WF (2007) Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66(5):607–618CrossRefGoogle Scholar
  2. 2.
    Funder JW, Carey RM, Mantero F et al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(5):1889–1916CrossRefGoogle Scholar
  3. 3.
    Milliez P, Girerd X, Plouin PF et al (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45(8):1243–1248CrossRefGoogle Scholar
  4. 4.
    Rossi GP, Bernini G, Desideri G et al (2006) Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 48(2):232–238CrossRefGoogle Scholar
  5. 5.
    Rossi GP, Sechi LA, Giacchetti G et al (2008) Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19(3):88–90CrossRefGoogle Scholar
  6. 6.
    Quillo AR, Grant CS, Thompson GB et al (2011) Primary aldosteronism: results of adrenalectomy for nonsingle adenoma. J Am Coll Surg 213(1):106–112CrossRefGoogle Scholar
  7. 7.
    Trésallet C, Salepçioglu H, Godiris-Petit G et al (2010) Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. Surgery 148(1):129–134CrossRefGoogle Scholar
  8. 8.
    Novitsky YW, Kercher KW, Rosen MJ et al (2005) Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery 138(6):1009–1017CrossRefGoogle Scholar
  9. 9.
    Morioka M, Kobayashi T, Sone A et al (2008) Primary aldosteronism due to unilateral adrenal hyperplasia. Report of two cases and review of the literature. Endocr J 47(4):443–449CrossRefGoogle Scholar
  10. 10.
    Iacobone M, Citton M, Viel G et al (2012) Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. Surgery 152(6):1248–1255CrossRefGoogle Scholar
  11. 11.
    Leung A, Sasano H, Nishikwa T et al (2013) Multiple unilateral adrenal adenomas in a patient with primary hyperaldosteronism. Endocr Pract 14(1):76–79CrossRefGoogle Scholar
  12. 12.
    Hashimoto N, Kawamura Y, Nakamura T et al (2011) A case of primary aldosteronism caused by multiple adrenocortical macronodules. Intern Med 50(6):585–590CrossRefGoogle Scholar
  13. 13.
    Stowasser M, Gordon RD (2013) The renaissance of primary aldosteronism: What has it taught us? Hear Lung Circ 22(6):412–420CrossRefGoogle Scholar
  14. 14.
    Walz MK, Gwosdz R, Levin SL et al (2008) Retroperitoneoscopic adrenalectomy in Conn’s syndrome caused by adrenal adenomas or nodular hyperplasia. World J Surg 32(5):847–853. CrossRefPubMedGoogle Scholar
  15. 15.
    Sigurjonsdottir HA, Gronowitz M, Andersson O et al (2012) Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord 12:17CrossRefGoogle Scholar
  16. 16.
    Weisbrod AB, Webb RC, Mathur A et al (2013) Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism. Ann Surg Oncol 20(3):753–758CrossRefGoogle Scholar
  17. 17.
    Obara T, Ito Y, Okamoto T et al (1992) Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 112(6):987–993PubMedGoogle Scholar
  18. 18.
    Ito Y, Fujimoto Y, Obara T, Kodama T (1990) Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma. World J Surg 14(3):330–334. CrossRefPubMedGoogle Scholar
  19. 19.
    Hennings J, Andreasson S, Botling J et al (2010) Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism. Langenbeck’s Arch Surg 395(2):133–137CrossRefGoogle Scholar
  20. 20.
    Gioco F, Seccia TM, Gomez-Sanchez EP et al (2015) Adrenal histopathology in primary aldosteronism: Is it time for a change? Hypertension 66(4):724–730CrossRefGoogle Scholar
  21. 21.
    Mete O, Duan K (2018) The many faces of primary aldosteronism and cushing syndrome: a reflection of adrenocortical tumor heterogeneity. Front Med 5:54CrossRefGoogle Scholar
  22. 22.
    Young WF, Stanson AW (2009) What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) 70(1):14–17CrossRefGoogle Scholar
  23. 23.
    Zhang Z, Meng H, Hou Z et al (2013) Fetal adrenal gland in the second half of gestation: morphometrical assessment with 3.0T post-mortem MRI. PLoS ONE 8(10):e75511CrossRefGoogle Scholar
  24. 24.
    Lam KY, Chan ACL, Lo CY (2001) Morphological analysis of adrenal glands: a prospective analysis. Endocr Pathol 12(1):33–38CrossRefGoogle Scholar
  25. 25.
    Katayama Y, Takata N, Tamura T et al (2005) A case of primary aldosteronism due to unilateral adrenal hyperplasia. Hypertens Res 28(4):379–384CrossRefGoogle Scholar
  26. 26.
    Proye CAG, Mulliez EAR, Carnaille BML et al (1998) Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery 124(6):1128–1133CrossRefGoogle Scholar
  27. 27.
    Walz MK, Peitgen K, Saller B et al (1998) Subtotal adrenalectomy by the posterior retroperitoneoscopic approach. World J Surg 22(6):621–627. CrossRefPubMedGoogle Scholar
  28. 28.
    Ishidoya S, Ito A, Sakai K et al (2005) Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 174(1):40–43CrossRefGoogle Scholar
  29. 29.
    Nanba AT, Nanba K, Byrd JB et al (2017) Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clin Endocrinol (Oxf) 87(6):665–672CrossRefGoogle Scholar
  30. 30.
    Volpe C, Hamberger B, Höög A et al (2015) Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy. Clin Endocrinol (Oxf) 82(5):639–647CrossRefGoogle Scholar
  31. 31.
    Swearingen AJ, Kahramangil B, Monteiro R et al (2018) Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism. Surgery 163(4):807–810CrossRefGoogle Scholar
  32. 32.
    Kline GA, Darras P, Leung AA et al (2018) Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling. J Hypertens 37(3):596–602CrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2019

Authors and Affiliations

  • Omair A. Shariq
    • 1
    Email author
  • Kabir Mehta
    • 1
  • Geoffrey B. Thompson
    • 1
  • Melanie L. Lyden
    • 1
  • David R. Farley
    • 1
  • Irina Bancos
    • 2
  • Benzon M. Dy
    • 1
  • William F. YoungJr.
    • 2
  • Travis J. McKenzie
    • 1
  1. 1.Department of SurgeryMayo ClinicRochesterUSA
  2. 2.Division of Endocrinology, Diabetes, Metabolism, and NutritionMayo ClinicRochesterUSA

Personalised recommendations